CervoMed Inc.

Ownership Transactions Reported by 23 Insiders

Symbol
CRVO on Nasdaq
Industry
Pharmaceutical Preparations
Location
20 Park Plaza, Suite 424, Boston, MA

Insiders trading volume in the past year

CervoMed Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Sylvie Gregoire Director, 10%+ Owner $12.7M +$283K +2.28% Nov 17, 2025
John J. Alam CEO & President, Director, 10%+ Owner $12.7M +$283K +2.28% Nov 17, 2025
Matthew Winton Chief Commercial and Business $119K +$117K +5525% Nov 17, 2025
William R. Elder CFO, GC & Secretary $104K +$91.1K +706% Nov 17, 2025
Diana M. Lanchoney Director $5.34K Jun 30, 2023
Jeffrey V. Poulton Director Jun 23, 2025
David Quigley Director Oct 27, 2025
Kelly Blackburn SVP, Clinical Development Feb 4, 2025
John William Tanner Chief Financial Officer Jan 26, 2024
Robert Joseph Cobuzzi Jr. Chief Operating Officer Feb 4, 2025
Marwan Sabbagh Director Jun 23, 2025
Mark De Rosch EVP, RA and GA and PgM May 1, 2025
Frank Zavrl Director Jun 23, 2025
Jill Davidson Director Sep 15, 2023
Jane H. Hollingsworth Director Jun 23, 2025
Joshua S. Boger Director, 10%+ Owner Jun 23, 2025
Alan G. Levin Director Jul 1, 2021
Mark T. Giles Director Jul 1, 2021
Raven Jaeger Chief Regulatory Officer Jun 7, 2022
Eric Francois Director Jul 1, 2021
Christopher D. Galloway Chief Medical Officer Jan 27, 2022
William Karl Hornung Chief Financial Officer Jan 27, 2022
Robert W. Adams Director Jul 1, 2021

Recent Insider Transactions by Companies or Individuals for CervoMed Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.